Motif Bio plc ADRs
MTFB
MTFB was delisted on the 16th of December, 2019.
3 hedge funds and large institutions have $10.4M invested in Motif Bio plc ADRs in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
12% less capital invested
Capital invested by funds: $11.8M → $10.4M (-$1.42M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$12.6K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2K |
MTFB Hedge Fund Activity: Q1 2018 in Review
3 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q1 2018, worth a combined $10.4M — down 12% from $11.8M a quarter earlier.
Fund positioning in MTFB was balanced in Q1 2018: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $12.6K. The largest seller was Deutsche Bank, exiting entirely with an estimated $2K sold.
- 3 institutional investors held Motif Bio plc ADRs (MTFB) as of Q1 2018, unchanged from Q4 2017.
- Funds reported $10.4M of Motif Bio plc ADRs stock for Q1 2018, down 12% quarter-over-quarter.
- 1 fund opened new Motif Bio plc ADRs positions in Q1 2018 and 1 closed out, a net change of 0 holders.
- The largest Motif Bio plc ADRs buyer in Q1 2018 was UBS Group, an estimated $12.6K added.
- The largest Motif Bio plc ADRs seller in Q1 2018 was Deutsche Bank, an estimated $2K sold.
Based on aggregated 13F filings for Q1 2018.